Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Clinical Chemistry
|
January 1, 2014
Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification
Shari S Bassuk, JoAnn E Manson
Cardiovascular Research
|
November 15, 2022
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence
Shari S Bassuk, JoAnn E Manson,
NAM Perspectives
|
March 4, 2025
Population Health: The Power of Prevention
JoAnn E Manson, Shari S Bassuk
Journal of Clinical Epidemiology
|
August 19, 2003
Characteristics of the Modified Mini-Mental State Exam among elderly persons
Shari S Bassuk, Jane M Murphy
Annals of Internal Medicine
|
February 5, 2020
Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy
JoAnn E Manson, Shari S Bassuk
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
August 17, 2005
Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease
Shari S Bassuk, JoAnn E Manson
JAMA
|
January 9, 2003
Obesity in the United States: a fresh look at its high toll
JoAnn E Manson, Shari S Bassuk
American Journal of Epidemiology
|
May 24, 2017
Invited Commentary: The Framingham Offspring Study-A Pioneering Investigation Into Familial Aggregation of Cardiovascular Risk
JoAnn E Manson, Shari S Bassuk
Metabolism: Clinical and Experimental
|
December 10, 2014
Biomarkers of cardiovascular disease risk in women
JoAnn E Manson, Shari S Bassuk
Metabolism: Clinical and Experimental
|
April 18, 2016
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
Shari S Bassuk, JoAnn E Manson
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Clinical Chemistry
|
January 1, 2014
Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification
Shari S Bassuk, JoAnn E Manson
Cardiovascular Research
|
November 15, 2022
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence
Shari S Bassuk, JoAnn E Manson,
NAM Perspectives
|
March 4, 2025
Population Health: The Power of Prevention
JoAnn E Manson, Shari S Bassuk
Journal of Clinical Epidemiology
|
August 19, 2003
Characteristics of the Modified Mini-Mental State Exam among elderly persons
Shari S Bassuk, Jane M Murphy
Annals of Internal Medicine
|
February 5, 2020
Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy
JoAnn E Manson, Shari S Bassuk
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
August 17, 2005
Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease
Shari S Bassuk, JoAnn E Manson
JAMA
|
January 9, 2003
Obesity in the United States: a fresh look at its high toll
JoAnn E Manson, Shari S Bassuk
American Journal of Epidemiology
|
May 24, 2017
Invited Commentary: The Framingham Offspring Study-A Pioneering Investigation Into Familial Aggregation of Cardiovascular Risk
JoAnn E Manson, Shari S Bassuk
Metabolism: Clinical and Experimental
|
December 10, 2014
Biomarkers of cardiovascular disease risk in women
JoAnn E Manson, Shari S Bassuk
Metabolism: Clinical and Experimental
|
April 18, 2016
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
Shari S Bassuk, JoAnn E Manson
Page
of 5